DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
Go back to DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care| DaVita Inc. (NYSE: DVA) | Delayed: 176.81 +1.46 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $175.35 | 52 Week High | $78.77 | |||
| Open | $171.78 | 52 Week Low | $55.00 | |||
| Day High | $177.48 | P/E | 61.18 | |||
| Day Low | $171.78 | EPS | $2.89 | |||
| Volume | 1,140,389 | |||||



